Ovarian Hyperstimulation and Fibrin Clot Properties.

Exclusion Criteria14

• ovarian involvement
• oral contraceptives use within previous 3 months
• dienogest therapy within 3 months until ART
• thrombotic events in the medical history
• severe hypertension
• diabetes mellitus
• the presence of known VTE risk factors, including obesity, recent major surgery with prolonged immobilization or trauma,
• deficiency of antithrombin, protein C or protein S,
• antiphospholipid syndrome,
• known malignancy,
• any chronic inflammatory diseases (e.g. rheumatoid arthritis)
• advanced chronic renal disease (estimated glomerular filtration rate \[eGFR\] <30 ml/min),
• international normalized ratio (INR) more than 1.2 at the day of blood draw
• pregnancy.